Marcus Bantscheff

Cellzome, a GSK Company


Marcus Bantscheff graduated in Chemistry at the University of Konstanz and obtained his PhD degree from the University of Rostock working with Prof. Glocker on structure-function correlation of bacterial response regulator proteins utilizing mass spectrometric and protein chemistry methods. As a postdoctoral fellow at the Proteome Center in Rostock, Marcus was involved in setting up a proteomics unit and focused on the analysis of synovial fluids and tissue samples derived from rheumathoid arthritis patients and CIA mice. At Cellzome since 2002, he focuses on the development and application of proteomics and chemical biology approaches to characterize targets and mechanism-of-action of bioactive molecules. Marcus is an inventor on several patents including Cellzome’s Kinobeads™ technology, has co-authored more than 70 publications, and serves as a reviewer for reputed journals and funding bodies. He is a member of the scientific advisory board of Denator AB, the industry advisory board of Hochschule Mannheim and the editorial board of Molecular and Cellular Proteomics. In 2016 his research was awarded with the Life Science price of the German Society for Mass Spectrometry. Marcus is a Senior Scientific Director at GSK and a Senior Fellow and in his current position, he leads the proteomics platform at Cellzome, A GSK company.